These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Reasons to be cautious about cholesterol lowering drugs. Struthers M BMJ; 2008 Sep; 337():a1493. PubMed ID: 18768557 [No Abstract] [Full Text] [Related]
6. Premature release of data from clinical trials of ezetimibe. Califf RM; Harrington RA; Blazing MA N Engl J Med; 2009 Aug; 361(7):712-7. PubMed ID: 19675335 [No Abstract] [Full Text] [Related]
7. Preliminary observations from preliminary trial results: have we finally had enough? Taylor AJ; Nissen SE Circ Cardiovasc Qual Outcomes; 2008 Sep; 1(1):54-7. PubMed ID: 20031788 [No Abstract] [Full Text] [Related]
8. Simvastatin + ezetimibe: a combination with no proven advantages. Prescrire Int; 2007 Apr; 16(88):67. PubMed ID: 17460829 [No Abstract] [Full Text] [Related]
9. Increased epistaxis with use of ezetimibe/simvastatin. Shah B; McAllister A; Davidson TM Ann Pharmacother; 2009 Sep; 43(9):1545. PubMed ID: 19671801 [No Abstract] [Full Text] [Related]
10. Identifying and addressing safety signals in clinical trials. Fleming TR N Engl J Med; 2008 Sep; 359(13):1400-2. PubMed ID: 18768938 [No Abstract] [Full Text] [Related]
12. [On the current debate on lowering LDL cholesterol with ezetimibe]. Breuer HW Dtsch Med Wochenschr; 2010 Nov; 135(44):2201; author reply 2202. PubMed ID: 20979008 [No Abstract] [Full Text] [Related]
13. Rx for uncertainty. Does a popular cholesterol-lowering drug do what it's supposed to do? Law BM Diabetes Forecast; 2008 Mar; 61(3):19. PubMed ID: 18446972 [No Abstract] [Full Text] [Related]